COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021)
- Record Type:
- Journal Article
- Title:
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021)
- Main Title:
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- Authors:
- Avouac, Jérôme
Drumez, Elodie
Hachulla, Eric
Seror, Raphaèle
Georgin-Lavialle, Sophie
El Mahou, Soumaya
Pertuiset, Edouard
Pham, Thao
Marotte, Hubert
Servettaz, Amélie
Domont, Fanny
Chazerain, Pascal
Devaux, Mathilde
Claudepierre, Pascal
Langlois, Vincent
Mekinian, Arsène
Maria, Alexandre Thibault Jacques
Banneville, Béatrice
Fautrel, Bruno
Pouchot, Jacques
Thomas, Thierry
Flipo, René-Marc
Richez, Christophe
Aeschlimann, Florence
Agard, Christian
Ait-Abdallah, Nassim
Albert, Jean-David
Alcais, Didier
Allain, Jean-Sébastien
Allanore, Yannick
Amador-Borreiro, Blanca
Amoura, Zahir
Andre, Emma
Arbault, Anaïs
Arlet, Jean-Benoît
Arnaud, Laurent
Arniaud, Denis
Arty-Hue, Herliette
Atlan, Lucie
Audemard-Verger, Alexandra
Audoin-Pajot, Christine
Audren, Victor
Bach-Bunner, Maxime
Bacquet-Deschryver, Hélène
Bader-Meunier, Brigitte
Balandraud, Nathalie
Balblanc, Jean-Charles
Bally, Stéphane
Banal, Frédéric
Barbery, Pierre
Barnetche, Thomas
Barrelet, Audre
Basch, André
Baumier, Vincent
Bayer, Guillaume
Bayle, Sophie
Beauvais, Catherine
Beinat, Rudie
Belin, Véronique
Belkhir, Rakiba
Benainous, Ruben
Belot, Alexandre
Benammar, Mohammed
Benhamou, Mathilde
Benhamou, Ygal
Benmansour, Ahmed
Bennet, Pascal
Bernoux-Manat, Brigitte
Berthet, Elise
Berthoux, Emilie
Bertolini, Ewa
Bigot, Adrien
Bisson-Vaivre, Aurélia
Blaison, Gilles
Bolla, Gilles
Bonidan, Olivier
Bonnet, Christine
Borie, Raphaël
Bossert, Marie
Boudou, Laurence
Bouhour, Françoise
Bouiller, Kévin
Bouldoires, Bastien
Boussoualim, Karima
Bouvard, Eric
Brondino, Regine
Buchlin, Pierre
Cabantous, Laurence
Cacoub, Patrice
Cadiou, Simon
Carteni, Maurizio
Carbasse, Aurélia
Castel, Brice
Cathebras, Pascal
Caumont, Hervé
Celant, Annalisa
Chaigne, Benjamin
Chaillous, Benoît
Champy, Romuald
Charcot, Agnès
Charles, Pierre
Charlot-Lambrecht, Isabelle
Charpin, Caroline
Chatelus, Emmanuel
Chaudier, Bernard
Chertok, Pascale
Chevalier, Xavier
Chevreau, Maxime
Chotard, Emilie
Chu Miow Lin, Delphine
Clavel, Gaëlle
Clavel-Osorio, Cyril
Cohen, Fleur
Cohen, Gregory
Colette-Cedoz, Marie-Eve
Collercandy, Nived
Colombey, Antoine
Comarmond, Chloé
Combe, Bernard
Comparon, Céline
Constant, Elodie
Coquerelle, Pascal
Corli, Justine
Corre, Clémence
Costedoat-Chalumeau, Nathalie
Couret, Marie
Courvoisier, Natacha
Coury-Lucas, Fabienne
Coutarel, Cécile
Coutier, Fabrice
Damade, Richard
Daver-Malaterre, Laurence
Dehimat, Sarahe
Delahousse, Michel
Barrois-Delattre, Emilie
Denarie, Delphine
Deprouw, Camille
Dernis, Emanuelle
Deroux, Alban
Desbarbieux, Renaud
Descamps, Elise
Deslandre, Chantal
Desmurs, Marie
Despaux, Jacques
Desplats, Marie
Detree, Frédérick
Devauchelle-Pensec, Valérie
Dhote, Robin
Dieude, Philippe
Dieudonne, Yannick
Diot, Elisabeth
Direz, Guillaume
Djeddi, Djamal-Dine
Douvier, Sarah
Drouet, Béatrice
Drumez, Elodie
Duc, Catherine
Ducornet, Angélique
Dufauret-Lombard, Carine
Duhamel, Alain
Dumaine, Cécile
Dumel, Anne-Elisabeth
Dumoulin-Richez, Chantal
Duquesne, Agnès
Durand, Géraldine
Durandin-Truffinet, Mariane
Duret, Pierre-Marie
Duval, Maïka
Ebbo, Mikaël
Ebstein, Esther
Economu-Dubosc, Andra
Emilie, Stéphanie
Euvrard, Romain
Evon, Philippe
Fabre, Sylvie
Fagedet, Dorothée
Farhat, Meryem
Fauconier, Marion
Fechtenbaum, Jacques
Felten, Renaud
Fernandes, Fanny
Ferreira-Maldent, Nicole
Feurer, Elodie
Fichet, Amandine
Flaisler, Françoise
Florens, Nans
Foltz, Violaine
Fontanges, Elisabeth
Foret, Jennifer
Fougerousse, Anne-Claire
Fouque-Aubert, Anne
Foutrier-Morello, Catherine
Francois-Pradier, Hélène
Frantzen, Léa
Fritz, Pierre
Froissart, Antoine
Fulpin, Jean
Fuzibet, Piera
Gaches, Francis
Gagneux-Lemoussu, Laurence
Penhoat-Gahier, Mélanie
Galland, Joris
Gandjbakhch, Frédérique
Garnier, Nicole
Garraud, Thomas
Garrot, Jean-François
Gastaldi, Romain
Gaud-Listrat, Véronique
Gauthier-Prieur, Maud
Georgescu, Dana
Gerard, Nathalie
Gervais, Elisabeth
Gibert, Christelle
Gibert, Eric
Gill, Ghislaine
Gillard, Jérôme
Gilson, Mélanie
Gimonnet, Pauline
Giraudet-Le Quintrec, Jeanine-Sophie
Giraud-Morelet, Aude
Glace, Baptiste
Glanowski, Camille
Godeau, Bertrand
Gombert, Bruno
Gonnet-Gracia, Camille
Goulenok, Tiphaine
Goupille, Philippe
Gourmelen, Olivier
Govindaraju-Audouard, Sophie
Grados, Franck
Grall-Lerosey, Martine
Grardel, Bruno
Grasland, Anne
Grateau, Gilles
Groza, Monica
Guillaud, Constance
Guillaume, Séverine
Guillibert, Caroline
Guillot, Xavier
Guilpain, Philippe
Gury, Aline
Guyot, Marie-Hélène
Hacquard-Bouder, Cécile
Havard, Marie-Noelle
Hellier, Jean-Pierre
Hennequin, Pascal
Henriot, Basile
Henry, Julien
Hentgen, Véronique
Hermet, Marion
Herasse, Muriel
Hernandez, Julie
Hie, Miguel
Hilliquin, Pascal
Hinschberger, Olivier
Hittinger-Roux, Ambre
Holubar, Jan
Hudry, Christophe
Huguenel, Serge
Jaccard, Clara
Jacquemier, Jean-Michel,
Jamard, Bénédicte
Jan, Catherine
Jean, Sylvie
Jouvray, Mathieu
Juge, Pierre-Antoine
Juillard, Laurent
Jullien, Denis
Kabala, Anna
Kabchou, Abdelkrim
Karkowski, Ludovic
Karman, Françoise
Kemiche, Farid
Keraen, Jérémy
Kieffer, Pierre
Kone-Paut, Isabelle
Koreichi, Abdeldajallil
Kostine, Marie
La Batide Alanore, Sylvain
Lafforgue, Pierre
Lahalle, Sophie
Lambert, Marc
Lambrecht, Isabelle
Lanot, Sylvain
Lanteri, Aurélia
Larbre, Jean-Paul
Latourte, Augustin
Lavigne, Christian
Le Guen Guegan, Sophie
Le Guenno, Guillaume,
Leguy, Diane
Lebrun, Agnès
Ledoult, Emmanuel
Legoupil, Nathalie
Legrand, Erick
Lejeune, Charlotte
Leloire, Olivier
Leroux, Christophe
Leroy, Rémi
Leroy-Gouix, Marie
Leturcq, Tifenn
Leurs, Amélie
Leveque-Michaud, Céline
Limbach, François-Xavier
Liote, Frédéric
Lohse, Anne
Lozac'h, Pierre
Lucas, Virginie
Madelon, Aurélie
Magy-Bertrand, Nadine
Mahevas, Matthieu
Maillard, Hélène
Maillet, Thibault
Malochet-Guinamand, Sandrine
Mangon, Quentin
Marchou-Lopez, Sylvie
Margarit, Nathalie
Marhadour, Thierry
Mariette, Xavier
Martin, Claire
Mathian, Alexis
Maurier, François
Maury, Frédéric
Mazet-Guillaume, Betty
Mazouyez, Arnaud
Mazyad, Hassan
Mehsen-Cetre, Nadia
Meinzer, Ulrich
Melki, Isabelle
Messer, Laurent
Miceli, Corinne
Michaud, Martin
Michel, Catherine
Michel, Matthias
Michon, Mathilde
Milesi-Lecat, Anne-Marie
Molto, Anna
Moly, Marie
Moranne, Olivier
Morel, Gautier
Morel, Hugo
Morel, Jacques
Morin, Franck
Moulinier, Laurence
Moulis, Guillaume
Moura, Bertrand
Nguyen, Minh
Nicolas-Vullierme, Sabine
Nielly, Hubert
Nocturne, Gaétane
Nottez, Aurore
Ollagnon, Henri-Olivier
Pacaud-Vitoux, Isabelle
Pagnier, Anne
Paris, Caroline
Parrot, Antoine
Pascart, Tristan
Pascaud-Mansour, Yasmina
Paulin, Lætitia
Pavy, Stephan
Perard, Laurent
Pers, Yves-Marie
Pha, Micheline
Pichon, Maud
Pierreisnard, Audrey
Pizana, Gabrielle
Poignant, Sylvaine
Poix, Elsa
Portier, Agnès
Poulet, Antoine
Plassard, Samira
Pugnet, Grégory
Puyraimond-Zemmour, Déborah
Quartier-Dit-Maire, Pierre
Quenet, Marion
Queyrel, Viviane
Raffray, Loïc
Remy, Philippe
Renard, Myriam
Rene, Jessica
Revuz, Sabine
Rey, Bénédicte
Richard-Colmant, Gaëlle
Riviere, Etienne
Riviere, Sébastien
Robin, Sophie
Rohmer, Julien
Roitg, Isabelle
Romier, Mélanie
Rolland, Michel
Roriz, Mélanie
Rosenberg, Carole
Rossi, Linda
Roth, Olivier
Rouidi, Sid-Ahmed
Roumier, Mathilde
Rousiere, Mickaël
Rousselin, Clémentine
Rouviere, Bénédicte
Roux, Christian
Roux, Fabienne
Roux, Marielle
Roux, Nicolas
Rouzaud, Diane
Rozenberg, Sylvie
Sacco, Isabelle
Sadji, Fatiha
Sailler, Laurent
Salliot, Carine
Salmon, Jean-Hugues
Saraux, Alain
Schmidt, Jean
Seguier, Julie
Sellam, Jérémie
Senbel, Eric
Sene, Thomas
Senet, Patricia
Seve, Pascal
Sicaud, Aurélie
Smets, Perrine
Sobanski, Vincent
Sordet, Christelle
Sornay-Rendu, Elisabeth
Souchaud-Debouverie, Odile
Sparsa, Lætitia
Spielmann, Lionel
Steib, Sarah
Stavris, Chloé
Straus, Catherine
Strotz, Victor
Szafors, Paulina
Taffignon-Clave, Séverine
Simoens, Justine
Theillac, Claire
Tenenbaum, Nora
Thomachot, Benoît
Tieulie, Nathalie
Tiriau, Soizic
Tison, Alice
Toussirot, Eric
Trefond, Ludovic
Trijau, Sophie
Trouillier, Sébastien
Trouvin, Anne-Priscille
Truchetet, Marie-Elise
Ulrich, Marc
Vaquier, Jacques
Veillard, Eric
Veillon, Laurent
Veillard, Eric
Veillon, Laurent
Vial, Guillaume
Viallard, Jean-François
Victor, Judith
Vidon, Claire
Vidon, Mathias
Vigne, Camille
Virone, Alexandre
Warzocha, Ursula
Wendling, Daniel
Werle, Claude
Wibaux, Cécile
Willems, Alexandra
Wisniewski, Michel
Woessner, Juliette
Xerri-Campano, Bernadette
… (more) - Abstract:
- Summary: Background: Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab. We aimed to investigate whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases. Methods: In this cohort study, we analysed data from the French RMD COVID-19 cohort, which included patients aged 18 years or older with inflammatory rheumatic and musculoskeletal diseases and highly suspected or confirmed COVID-19. The primary endpoint was the severity of COVID-19 in patients treated with rituximab (rituximab group) compared with patients who did not receive rituximab (no rituximab group). Severe disease was defined as that requiring admission to an intensive care unit or leading to death. Secondary objectives were to analyse deaths and duration of hospital stay. The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis vs others]). Odds ratios and hazard ratios and their 95% CIs were calculated as effect size, by dividing the two population mean differences bySummary: Background: Various observations have suggested that the course of COVID-19 might be less favourable in patients with inflammatory rheumatic and musculoskeletal diseases receiving rituximab compared with those not receiving rituximab. We aimed to investigate whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases. Methods: In this cohort study, we analysed data from the French RMD COVID-19 cohort, which included patients aged 18 years or older with inflammatory rheumatic and musculoskeletal diseases and highly suspected or confirmed COVID-19. The primary endpoint was the severity of COVID-19 in patients treated with rituximab (rituximab group) compared with patients who did not receive rituximab (no rituximab group). Severe disease was defined as that requiring admission to an intensive care unit or leading to death. Secondary objectives were to analyse deaths and duration of hospital stay. The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis vs others]). Odds ratios and hazard ratios and their 95% CIs were calculated as effect size, by dividing the two population mean differences by their SD. This study is registered with ClinicalTrials.gov, NCT04353609 . Findings: Between April 15, 2020, and Nov 20, 2020, data were collected for 1090 patients (mean age 55·2 years [SD 16·4]); 734 (67%) were female and 356 (33%) were male. Of the 1090 patients, 137 (13%) developed severe COVID-19 and 89 (8%) died. After adjusting for potential confounding factors, severe disease was observed more frequently (effect size 3·26, 95% CI 1·66–6·40, p=0·0006) and the duration of hospital stay was markedly longer (0·62, 0·46–0·85, p=0·0024) in the 63 patients in the rituximab group than in the 1027 patients in the no rituximab group. 13 (21%) of 63 patients in the rituximab group died compared with 76 (7%) of 1027 patients in the no rituximab group, but the adjusted risk of death was not significantly increased in the rituximab group (effect size 1·32, 95% CI 0·55–3·19, p=0·53). Interpretation: Rituximab therapy is associated with more severe COVID-19. Rituximab will have to be prescribed with particular caution in patients with inflammatory rheumatic and musculoskeletal diseases. Funding: None. … (more)
- Is Part Of:
- Lancet. Volume 3:Number 6(2021)
- Journal:
- Lancet
- Issue:
- Volume 3:Number 6(2021)
- Issue Display:
- Volume 3, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 3
- Issue:
- 6
- Issue Sort Value:
- 2021-0003-0006-0000
- Page Start:
- e419
- Page End:
- e426
- Publication Date:
- 2021-06
- Subjects:
- Rheumatology -- periodicals
616.72305 - Journal URLs:
- https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/S2665-9913(21)00059-X ↗
- Languages:
- English
- ISSNs:
- 2665-9913
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16991.xml